{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:54:44Z","timestamp":1794455684505,"version":"4.9.1"},"posted":{"date-parts":[[2025,4,21]]},"group-title":"In Review","reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,6]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background<\/bold>\n                  Little is known about the prevalence of Oral Human Papilloma Virus (OHPV) in people living with HIV (PLWHIV) in the East African region. The objective of this study was to document the prevalence and types OHPV infection in a large cohort of PLWHIV attending an urban HIV clinic in Eastern Africa\n                  <bold>Methods<\/bold>\n                  This was a cross-sectional study among 1,715 participants of the Makerere University Joint AIDS Program clinic, located in Kampala, Uganda, in East Africa. A salivary sample was collected from which DNA was extracted and subjected to a Polymerase Chain Reaction (PCR) based typing. Data analysis was carried out among participants with complete data (n\u2009=\u20091,243) and relied on descriptive statistics (frequencies, percentages), bivariate testing and multivariate regression modeling, using a conventional p\u2009&lt;\u20090.05 statistical significance threshold.\n                  <bold>Results<\/bold>\n                  Participants had a mean age of 45 (SD\u2009=\u200910) years, most (69%) were female, and 67% were HPV positive. There was no association between participants\u2019 age or gender and the likelihood of them being diagnosed with HPV infection in this study. HPV type 45 was the most frequently (16%) identified HPV, while HPV type 18 (5%) and HPV type 16 (2.3%) were less frequently identified. Most of the HPV positive samples had more than one HPV type detected.\n                  <bold>Conclusion<\/bold>\n                  This study highlights the high prevalence of OHPV among PLWHIV, with HPV type 45 being the most frequently detected type, and smaller frequencies of vaccine targeted HPV 16 and HPV 18. Our findings highlight the need for continued surveillance and typing of circulating OHPV strains, particularly among PLWHIV, to inform evidence-based preventive strategies.\nClinical trial number: not applicable.\n                <\/p>","DOI":"10.21203\/rs.3.rs-5594024\/v1","type":"posted-content","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T01:37:26Z","timestamp":1745199446000},"source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Oral Human Papilloma virus infection in an East African HIV\/AIDS cohort: A cross-sectional study"],"prefix":"10.21203","author":[{"given":"Ian G.","family":"Munabi","sequence":"first","affiliation":[{"name":"Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane.","family":"Kamulegeya","sequence":"additional","affiliation":[{"name":"School of Dentistry, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunstan.","family":"Kalanzi","sequence":"additional","affiliation":[{"name":"School of Dentistry, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Kateete","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred Collins.","family":"Semitala","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine- Lutalo.","family":"Mwesigwa","sequence":"additional","affiliation":[{"name":"School of Dentistry, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel.","family":"Kalungi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mulago National Referral and Teaching Hospital, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Cameron","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center: New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon.","family":"Divaris","sequence":"additional","affiliation":[{"name":"Adams School of Dentistry, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William.","family":"Buwembo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3122\/jabfm.2015.04.140301","article-title":"The Growing Epidemic of HPV-Positive Oropharyngeal Carcinoma: A Clinical Review for Primary Care Providers","volume":"28","author":"Moore KA","year":"2015","unstructured":"Moore KA 2nd, Mehta V. The Growing Epidemic of HPV-Positive Oropharyngeal Carcinoma: A Clinical Review for Primary Care Providers. J Am Board Fam Med. 2015;28(4):498\u2013503.","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1099\/jgv.0.000727","article-title":"Oral human papillomavirus infection incidence and clearance: a systematic review of the literature","volume":"98","author":"Wood ZC","year":"2017","unstructured":"Wood ZC, Bain CJ, Smith DD, Whiteman DC, Antonsson A. Oral human papillomavirus infection incidence and clearance: a systematic review of the literature. J Gen Virol. 2017;98(4):519\u201326.","journal-title":"J Gen Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.oraloncology.2018.04.005","article-title":"The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis","volume":"82","author":"Tam S","year":"2018","unstructured":"Tam S, Fu S, Xu L, Krause KJ, Lairson DR, Miao H, Sturgis EM, Dahlstrom KR. The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018;82:91\u20139.","journal-title":"Oral Oncol"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1007\/s42770-021-00602-3","article-title":"HPV oral and oropharynx infection dynamics in young population","author":"Moran-Torres A","year":"2021","unstructured":"Moran-Torres A, Pazos-Salazar NG, Tellez-Lorenzo S, Jimenez-Lima R, Lizano M, Reyes-Hernandez DO, Marin-Aquino JJ, Manzo-Merino J. HPV oral and oropharynx infection dynamics in young population. Braz J Microbiol 2021.","journal-title":"Braz J Microbiol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"e0160099","DOI":"10.1371\/journal.pone.0160099","article-title":"Significantly Reduced Genoprevalence of Vaccine-Type HPV-16\/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16\/18 Vaccine (Cervarix(R)) Pilot Project in Uganda","volume":"11","author":"Kumakech E","year":"2016","unstructured":"Kumakech E, Berggren V, Wabinga H, Lillsunde-Larsson G, Helenius G, Kaliff M, Karlsson M, Kirimunda S, Musubika C, Andersson S. Significantly Reduced Genoprevalence of Vaccine-Type HPV-16\/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16\/18 Vaccine (Cervarix(R)) Pilot Project in Uganda. PLoS ONE. 2016;11(8):e0160099.","journal-title":"PLoS ONE"},{"issue":"16","key":"ref6","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2021.01.060","article-title":"Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines","volume":"39","author":"Stanley M","year":"2021","unstructured":"Stanley M, Joura E, Yen GP, Kothari S, Luxembourg A, Saah A, Walia A, Perez G, Khoury H, Badgley D, et al. Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines. Vaccine. 2021;39(16):2214\u201323.","journal-title":"Vaccine"},{"issue":"13","key":"ref7","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.vaccine.2016.02.019","article-title":"Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines","volume":"34","author":"Faust H","year":"2016","unstructured":"Faust H, Toft L, Sehr P, Muller M, Bonde J, Forslund O, Ostergaard L, Tolstrup M, Dillner J. Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines. Vaccine. 2016;34(13):1559\u201365.","journal-title":"Vaccine"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00404-020-05879-7","article-title":"Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008\u20132018, and perspectives on cancer prevention","volume":"303","author":"Du J","year":"2021","unstructured":"Du J, Ahrlund-Richter A, Nasman A, Dalianis T. Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008\u20132018, and perspectives on cancer prevention. Arch Gynecol Obstet. 2021;303(2):329\u201335.","journal-title":"Arch Gynecol Obstet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"106244","DOI":"10.1016\/j.oraloncology.2022.106244","article-title":"Impact of HPV vaccination on HPV-related oral infections","volume":"136","author":"Gheit T","year":"2023","unstructured":"Gheit T, Muwonge R, Lucas E, Galati L, Anantharaman D, McKay-Chopin S, Malvi SG, Jayant K, Joshi S, Esmy PO, et al. Impact of HPV vaccination on HPV-related oral infections. Oral Oncol. 2023;136:106244.","journal-title":"Oral Oncol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13027-021-00398-9","article-title":"Prevalence and genotype specific concordance of oro-genital and anal human papillomavirus infections among sexually active Nigerian women","volume":"16","author":"Morhason-Bello IO","year":"2021","unstructured":"Morhason-Bello IO, Baisley K, Pavon MA, Adewole IF, Bakare R, de Sanjose S, Francis SC, Watson-Jones D. Prevalence and genotype specific concordance of oro-genital and anal human papillomavirus infections among sexually active Nigerian women. Infect Agent Cancer. 2021;16(1):59.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12879-017-2937-0","article-title":"Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site","volume":"18","author":"Vergori A","year":"2018","unstructured":"Vergori A, Garbuglia AR, Piselli P, Del Nonno F, Sias C, Lupi F, Lapa D, Baiocchini A, Cimaglia C, Gentile M, et al. Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site. BMC Infect Dis. 2018;18(1):25.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12985-019-1132-x","article-title":"Alpha, Beta, gamma human PapillomaViruses (HPV) detection with a different sets of primers in oropharyngeal swabs, anal and cervical samples","volume":"16","author":"Sias C","year":"2019","unstructured":"Sias C, Salichos L, Lapa D, Del Nonno F, Baiocchini A, Capobianchi MR, Garbuglia AR. Alpha, Beta, gamma human PapillomaViruses (HPV) detection with a different sets of primers in oropharyngeal swabs, anal and cervical samples. Virol J. 2019;16(1):27.","journal-title":"Virol J"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/infdis\/jiv080","article-title":"Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients","volume":"212","author":"Muller K","year":"2015","unstructured":"Muller K, Kazimiroff J, Fatahzadeh M, Smith RV, Wiltz M, Polanco J, Grossberg RM, Belbin TJ, Strickler HD, Burk RD, et al. Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients. J Infect Dis. 2015;212(5):760\u20138.","journal-title":"J Infect Dis"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/inthealth\/ihz090","article-title":"Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project","volume":"12","author":"Kiwuwa-Muyingo S","year":"2020","unstructured":"Kiwuwa-Muyingo S, Abongomera G, Mambule I, Senjovu D, Katabira E, Kityo C, Gibb DM, Ford D, Seeley J. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project. Int Health. 2020;12(5):429\u201343.","journal-title":"Int Health"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"pkaa047","DOI":"10.1093\/jncics\/pkaa047","article-title":"Long-term Persistence of Oral HPV Over 7 Years of Follow-up","volume":"4","author":"D'Souza G","year":"2020","unstructured":"D'Souza G, Clemens G, Strickler HD, Wiley DJ, Troy T, Struijk L, Gillison M, Fakhry C. Long-term Persistence of Oral HPV Over 7 Years of Follow-up. JNCI Cancer Spectr. 2020;4(5):pkaa047.","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"e0168133","DOI":"10.1371\/journal.pone.0168133","article-title":"Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa","volume":"12","author":"Verma M","year":"2017","unstructured":"Verma M, Erwin S, Abedi V, Hontecillas R, Hoops S, Leber A, Bassaganya-Riera J, Ciupe SM. Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa. PLoS ONE. 2017;12(1):e0168133.","journal-title":"PLoS ONE"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13027-020-00301-y","article-title":"Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil","volume":"15","author":"Suehiro TT","year":"2020","unstructured":"Suehiro TT, Damke G, Damke E, de Azevedo Ramos PLR, de Andrade Pereira Silva M, Pelloso SM, Huh WK, Franco RAF, da Silva VRS, Scarinci IC, et al. Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil. Infect Agent Cancer. 2020;15:31.","journal-title":"Infect Agent Cancer"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092664","article-title":"Anti-Retroviral Protease Inhibitors Regulate Human Papillomavirus 16 Infection of Primary Oral and Cervical Epithelium","volume":"12","author":"Alam S","year":"2020","unstructured":"Alam S, Chatterjee S, Kang SD, Milici J, Biryukov J, Chen H, Meyers C. Anti-Retroviral Protease Inhibitors Regulate Human Papillomavirus 16 Infection of Primary Oral and Cervical Epithelium. Cancers (Basel) 2020, 12(9).","journal-title":"Cancers (Basel)"},{"key":"ref19","author":"Wood NH","year":"2020","unstructured":"Wood NH, Makua KS, Lebelo RL, Redzic N, Benoy I, Vanderveken OM, Bogers J. Human Papillomavirus Prevalence in Oral and Oropharyngeal Rinse and Gargle Specimens of Dental Patients and of an HIV-Positive Cohort from Pretoria, South Africa. Adv Virol 2020, 2020:2395219."},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s43058-021-00223-9","article-title":"Hypertension care cascade at a large urban HIV clinic in Uganda: a mixed methods study using the Capability, Opportunity, Motivation for Behavior change (COM-B) model","volume":"2","author":"Muddu M","year":"2021","unstructured":"Muddu M, Ssinabulya I, Kigozi SP, Ssennyonjo R, Ayebare F, Katwesigye R, Mbuliro M, Kimera I, Longenecker CT, Kamya MR, et al. Hypertension care cascade at a large urban HIV clinic in Uganda: a mixed methods study using the Capability, Opportunity, Motivation for Behavior change (COM-B) model. Implement Sci Commun. 2021;2(1):121.","journal-title":"Implement Sci Commun"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4314\/ahs.v20i1.18","article-title":"High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells\/microL in a program setting in Uganda","volume":"20","author":"Byonanebye DM","year":"2020","unstructured":"Byonanebye DM, Semitala FC, Katende J, Bakenga A, Arinaitwe I, Kyambadde P, Musinguzi P, Biraro IA, Byakika-Kibwika P, Kamya MR. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells\/microL in a program setting in Uganda. Afr Health Sci. 2020;20(1):132\u201341.","journal-title":"Afr Health Sci"},{"key":"ref22","article-title":"Periodontal health in a large cohort of Ugandansliving with HIV: A cross-sectional study","author":"William B","year":"2024","unstructured":"William B, Adriane K, Dunstan K, Naava NP, Proscovia N, Katete David P, Collins SF, Catherine ML, Samuel K, E CJ. : Periodontal health in a large cohort of Ugandansliving with HIV: A cross-sectional study. Res Sq 2024.","journal-title":"Res Sq"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/003335490912400320","article-title":"OpenEpi: a web-based epidemiologic and statistical calculator for public health","volume":"124","author":"Sullivan KM","year":"2009","unstructured":"Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009;124(3):471\u20134.","journal-title":"Public Health Rep"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12874-022-01694-7","article-title":"Sample size calculation for prevalence studies using Scalex and ScalaR calculators","volume":"22","author":"Naing L","year":"2022","unstructured":"Naing L, Nordin RB, Abdul Rahman H, Naing YT. Sample size calculation for prevalence studies using Scalex and ScalaR calculators. BMC Med Res Methodol. 2022;22(1):209.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21315\/mjms2021.28.2.2","article-title":"A Step-by-Step Process on Sample Size Determination for Medical Research","volume":"28","author":"Bujang MA","year":"2021","unstructured":"Bujang MA. A Step-by-Step Process on Sample Size Determination for Medical Research. Malays J Med Sci. 2021;28(2):15\u201327.","journal-title":"Malays J Med Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jviromet.2004.08.007","article-title":"Nested PCR with the PGMY09\/11 and GP5(+)\/6(+) primer sets improves detection of HPV DNA in cervical samples","volume":"122","author":"Fuessel Haws AL","year":"2004","unstructured":"Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK, Stisser K, Konig R, Tyring SK. Nested PCR with the PGMY09\/11 and GP5(+)\/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods. 2004;122(1):87\u201393.","journal-title":"J Virol Methods"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.42.7.3176-3184.2004","article-title":"Detection and typing of human papillomavirus by e6 nested multiplex PCR","volume":"42","author":"Sotlar K","year":"2004","unstructured":"Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004;42(7):3176\u201384.","journal-title":"J Clin Microbiol"},{"key":"ref29","author":"Bolker B","year":"2024","unstructured":"Bolker B, Robinson D. Broom. mixed: Tidying methods for mixed models. In: R package version 02. vol. 6; 2024: R package version 0.2.9.5."},{"key":"ref30","author":"Gohel D","year":"2024","unstructured":"Gohel D. Panagiotis Skintzos: _flextable: Functions for Tabular Reporting_. In., R package version 0.9.5 edn; 2024."},{"key":"ref31","author":"Bates D","year":"2015","unstructured":"Bates D, Maechler M, Bolker B, Walker S, Christensen RHB, Singmann H, Dai B, Grothendieck G, Green P, Bolker MB. Package \u2018lme4\u2019. convergence 2015, 12(1):2."},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.32614\/RJ-2017-066","article-title":"glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling","volume":"9","author":"Brooks ME","year":"2017","unstructured":"Brooks ME, Kristensen K, Van Benthem KJ, Magnusson A, Berg CW, Nielsen A, Skaug HJ, Machler M, Bolker BM. glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling. R J. 2017;9(2):378\u2013400.","journal-title":"R J"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan P","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349\u201359.","journal-title":"Int J Cancer"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1128\/JVI.03534-13","article-title":"Human papillomavirus 45 genetic variation and cervical cancer risk worldwide","volume":"88","author":"Chen AA","year":"2014","unstructured":"Chen AA, Heideman DA, Boon D, Gheit T, Snijders PJ, Tommasino M, Franceschi S, Clifford GM, Group IHVS. Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Virol. 2014;88(8):4514\u201321.","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13027-019-0250-9","article-title":"Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai","volume":"14","author":"Zhao J","year":"2019","unstructured":"Zhao J, Zhan Q, Guo J, Liu M, Ruan Y, Zhu T, Han L, Li F. Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai. Infect Agent Cancer. 2019;14:38.","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/oncolo\/oyae071","article-title":"Human malignancies associated with persistent HPV infection","volume":"29","author":"McBride AA","year":"2024","unstructured":"McBride AA. Human malignancies associated with persistent HPV infection. Oncologist. 2024;29(6):457\u201364.","journal-title":"Oncologist"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21873\/cdp.10283","article-title":"Prevalence of Multiple High Risk Human Papilloma Virus (HR-HPV) Infections in Cervical Cancer Screening in Lazio Region, Italy","volume":"4","author":"Pisani T","year":"2024","unstructured":"Pisani T, Cenci M. Prevalence of Multiple High Risk Human Papilloma Virus (HR-HPV) Infections in Cervical Cancer Screening in Lazio Region, Italy. Cancer Diagn Progn. 2024;4(1):42\u20135.","journal-title":"Cancer Diagn Progn"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12879-017-2832-8","article-title":"Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana","volume":"17","author":"Rantshabeng PS","year":"2017","unstructured":"Rantshabeng PS, Moyo S, Moraka NO, Ndlovu A, MacLeod IJ, Gaseitsiwe S, Kasvosve I. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana. BMC Infect Dis. 2017;17(1):731.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/infdis\/jiaa617","article-title":"Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity Cohort","volume":"223","author":"Kann H","year":"2021","unstructured":"Kann H, Lehtinen M, Eriksson T, Surcel HM, Dillner J, Faust H. Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity Cohort. J Infect Dis. 2021;223(11):1992\u20132000.","journal-title":"J Infect Dis"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"e0269655","DOI":"10.1371\/journal.pone.0269655","article-title":"Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda","volume":"17","author":"Patrick L","year":"2022","unstructured":"Patrick L, Bakeera-Kitaka S, Rujumba J, Malande OO. Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda. PLoS ONE. 2022;17(6):e0269655.","journal-title":"PLoS ONE"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson M","year":"2016","unstructured":"Brisson M, Benard E, Drolet M, Bogaards JA, Baussano I, Vanska S, Jit M, Boily MC, Smith MA, Berkhof J, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health. 2016;1(1):e8\u201317.","journal-title":"Lancet Public Health"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1186\/s12889-024-18977-x","article-title":"Risk factors associated with oral Human Papillomavirus (HPV) prevalence within a young adult population","volume":"24","author":"Whitton AF","year":"2024","unstructured":"Whitton AF, Knight GL, Marsh EK. Risk factors associated with oral Human Papillomavirus (HPV) prevalence within a young adult population. BMC Public Health. 2024;24(1):1485.","journal-title":"BMC Public Health"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009\u20132010","volume":"307","author":"Gillison ML","year":"2012","unstructured":"Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009\u20132010. JAMA. 2012;307(7):693\u2013703.","journal-title":"JAMA"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/CCO.0b013e32836242b4","article-title":"Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals","volume":"25","author":"Beachler DC","year":"2013","unstructured":"Beachler DC, D'Souza G. Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol. 2013;25(5):503\u201310.","journal-title":"Curr Opin Oncol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5594024\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5594024\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:16:55Z","timestamp":1764605815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5594024\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":44,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5594024\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12879-025-12198-2","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,4,21]]},"subtype":"preprint"}}